logo
Sign in

EUCR Stock Price, Chart, Stats & News

Eucrates Biomedical Acquisition Corp.
Save
42.23M
Market cap
47.81x
Current P/E
Forward P/E

EUCR chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
-128.84%
ROA
44.36%
ROE
10.27%
D/E
0.01x
Interest coverage ratio

EUCR valuation

P/E
47.81x
P/S
P/B
3.50x
P/CF
-47.45x
P/FCF
-67.00x
P/OCF
-47.45x
PEG
0.05x
EV multiple
-16.38x

About

Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe.

Similar securities

Based on sector and market capitalization

Report issue